Sign Up to like & get
recommendations!
1
Published in 2018 at "Current Oncology Reports"
DOI: 10.1007/s11912-018-0712-z
Abstract: Immunotherapy is rapidly transforming cancer care across a range of tumor types. Although Sipuleucel-T represented the first successful vaccine for the treatment of established cancer, other immunotherapeutic approaches for prostate cancer such as checkpoint inhibitors…
read more here.
Keywords:
cancer teaching;
prostate cancer;
immunotherapy prostate;
teaching old ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Cold Spring Harbor perspectives in medicine"
DOI: 10.1101/cshperspect.a030627
Abstract: Immunotherapy with agents that block immune checkpoints is a mainstay of therapy for several common tumor types; so far, prostate cancer is not among those treated using this method. The observed lack of activity in…
read more here.
Keywords:
cancer;
immunotherapy prostate;
prostate cancer;
Sign Up to like & get
recommendations!
1
Published in 2017 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-17-0019
Abstract: In the last few years, immunotherapy has become an important cancer treatment modality, and although the principles of immunotherapy have evolved over many decades, the FDA approvals of sipuleucel-T and ipilimumab began a new wave…
read more here.
Keywords:
cancer facts;
prostate cancer;
immunotherapy prostate;
facts hopes ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1021870
Abstract: COPYRIGHT © 2022 Galustian, Dalgleish, Bodman-Smith, Kusmartsev and Dasgupta. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is…
read more here.
Keywords:
prostate cancer;
immunological desert;
cancer turning;
turning immunological ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Investigative and Clinical Urology"
DOI: 10.4111/icu.20210369
Abstract: Despite the revolutionary progress in cancer treatment using immune checkpoint inhibitors (ICIs), remarkable responses in prostate cancer treatment have not yet been achieved. The disappointing previous results of ICIs have required further studies towards combined…
read more here.
Keywords:
cancer;
cancer requirements;
successful regime;
requirements successful ... See more keywords